Has Arlene Feder, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,621 in general payments to Arlene Feder, MD across 817 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Arlene Feder, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Arlene Feder, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Arlene Feder, MD

Endocrinology, Diabetes & Metabolism · Weirton, WVNPI 1508867979

Payments from drug & device makers

$19,621in general payments, 2019–2025

Across 817 payments — averaging $24.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$3K
Sanofi-aventis U.S. LLC$2K
Insulet Corporation$2K
Amneal Pharmaceuticals LLC$2K
Lilly USA, LLC$989
Corcept Therapeutics$863
plus $10K from 40 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	135	$2,534
Sanofi-aventis U.S. LLC	79	$2,479
Insulet Corporation	42	$1,530
Amneal Pharmaceuticals LLC	72	$1,504
Lilly USA, LLC	60	$989
Corcept Therapeutics	36	$863
Valeritas, Inc.	9	$860
AbbVie	33	$759
Amgen(2 entities)	42	$751
Xeris Pharmaceuticals, Inc.	46	$745
Mannkind Corporation	29	$739
Boehringer Ingelheim	21	$627
AstraZeneca(2 entities)	19	$506
Bayer	18	$479
Abbott	33	$469
Zealand Pharma US, Inc.	14	$389
Tandem Diabetes Care, Inc.	17	$361
Esperion Therapeutics, Inc.	9	$334
Cequr Corporation	4	$248
Radius Health, Inc.	13	$244
Recordati_rare_diseases_inc.	12	$230
Sanofi	2	$215
Sequel Med Tech, LLC	5	$210
Antares Pharma, Inc.	10	$197
Amarin Pharma, Inc.	9	$190
BETA Bionics, Inc.	4	$177
Johnson & Johnson	4	$174
Merck	6	$110
Novartis	5	$105
Amryt Pharma Holdings Ltd	2	$80
Ascendis Pharma Endocrinology Inc	3	$68
EUSA Pharma (US) LLC	3	$59
IBSA Pharma Inc.	3	$56
Neurocrine Biosciences, Inc.	2	$48
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$45
Pfizer	2	$41
Alfasigma USA, Inc.	2	$34
Almatica Pharma LLC	1	$25
Alvogen Inc	1	$24
Ultragenyx Pharmaceutical Inc.	1	$22
Dexcom, Inc.	1	$22
Ascensia Diabetes Care US Inc.	1	$19
Lifescan, Inc.	1	$19
Sun Pharmaceutical Industries Inc.	1	$16
Halozyme Inc	1	$15
Theracosbio, LLC	1	$11

How this compares

$19,621 in reported general payments places this provider in the 85th percentile of 57 endocrinology, diabetes & metabolism providers in West Virginia.

See all endocrinology, diabetes & metabolism providers in West Virginia →

Medicare billing

Part B allowed, 2024

$34,476

Medicare patients

158

Services billed

367

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Weirton

Viorica CrisanWeirton$32
Ayman ElkadryHuntington$767K
Daniel MaciasHuntington$686K
Zachary KistkaMartinsburg$120K
Jeremy SouleBridgeport$120K
Philip RyanMartinsburg$35K
John EplingBridgeport$28K
Greta GuyerSouth Charleston$22K
Ziad KahwashSouth Charleston$17K
Adnan HaiderMorgantown$13K

See the full list for West Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →